Advertisement
News
Advertisement

BG Medicine shares sink on widened loss, FDA setback

Thu, 08/09/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

BG Medicine, Inc. (BGMD), the maker of an FDA-approved diagnostic test for heart failure, saw its shares fall almost 6 percent Thursday. This followed the company reporting that its second quarter loss widened on increased costs, and that the company withdrew a diagnostic test from FDA consideration.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading